Moolec Science S.A.MLECWNASDAQ
Loading
| Metric | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +68.29% | -10.52% | +948.32% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | -93.30% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.66% | -0.10% | -3.58% | +2.32% | +3.05% |
| Weighted Average Shares Diluted Growth | +0.66% | -0.10% | -3.58% | +2.32% | +3.05% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +30866.92% | +85.31% | -12.37% | -10.41% | +128.16% |
| Inventory Growth | +0.00% | +0.00% | +1248.27% | +1329.07% | +865.90% |
| Asset Growth | -8.01% | +29.86% | +44.64% | +44.76% | +47.19% |
| Book Value per Share Growth | -44.19% | -42.66% | -30.05% | -37.42% | -59.40% |
| Debt Growth | +5109.27% | +8580.59% | +455.00% | +698.61% | +164.98% |
| R&D Expense Growth | +1243.47% | -22.30% | +13.56% | +9.75% | -29.71% |
| SG&A Expenses Growth | -96.41% | +137.28% | -41.79% | -16.80% | -41.96% |